Perfusion therapy for extremity melanoma. 1976

A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato

Because of their initial appearance on extremities, malignant melanomas lend themselves to isolated chemotherapeutic perfusions. Perfusion is attractive because one can deliver effective cytotoxic drugs without systemic toxicity. We are reviewing 20 patients treated between 1960 and 1973 with isolated perfusion. Melphalan (L-phenylalanine mustard) was the drug of choice. Eleven of the 20 patients had previous surgical treatment. Three of the 11 patients are still alive from 27 to 72 months postperfusion. Eight died after an average survival time of 33 months. Of the seven patients who underwent perfusion as primary therapy, four patients are alive from 25 to 76 months postperfusion, and three died after an average survival time of 34 months. There is direct correlation between stages and levels of melanoma, and perfusion and prolonged survival time.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010478 Chemotherapy, Cancer, Regional Perfusion Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D005260 Female Females

Related Publications

A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
April 1994, Surgical oncology,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
March 1994, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
January 1970, Archivum chirurgicum Neerlandicum,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
January 1992, Annals of plastic surgery,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
May 1965, Journal of the Tennessee Medical Association,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
July 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
June 1969, Annals of surgery,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
March 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
January 1970, Bulletin de la Societe internationale de chirurgie,
A S Brown, and M K Wallack, and J T Horstmann, and R W Hamilton, and J L Johnson, and F E Rosato
January 1968, Oncology,
Copied contents to your clipboard!